Carlos Garcia-Parada - Chief Financial Officer at Rocket Pharmaceuticals, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Stock Option (Right to Buy)	54K	$678K	$12.55	Feb 14, 2022	Direct	Common Stock
Restricted Stock Units	17.3K	$390K	$22.53	Feb 14, 2022	Direct	Common Stock

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.